CD8A and neoplasm: As for other cell components, both CA12 inhibitor and anti–PD-1 could increase the ratio of CD8+ T cells in total tumor leukocytes, with the combination treatment group exhibiting the most significant induction efficacy (Supplemental Figure 8D).